News
HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $18
4 Apr 24
News, Price Target, Analyst Ratings
Earnings Scheduled For March 21, 2024
21 Mar 24
Earnings
Fennec Pharmaceuticals Q4 EPS $(0.10) Misses $(0.02) Estimate, Sales $9.73M Beat $8.67M Estimate
21 Mar 24
Earnings, News
Fennec Pharmaceuticals's Earnings Outlook
20 Mar 24
Earnings
Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $18
18 Mar 24
News, Price Target, Analyst Ratings
Reported Sunday, Fennec Pharmaceuticals And Norgine Inked An Exclusive Licensing Agreement To Commercialize PEDMARQSI In Europe, Australia, And New Zealand
18 Mar 24
News
Press releases
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
17 Mar 24
Press Releases
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
29 Feb 24
Press Releases
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
1 Feb 24
Health Care, Press Releases